Broncho-Vaxom ® is an extract of different bacterial species frequently responsible of respiratory infections. It stimulates the immune system in order to increase the body’s natural defences against a wide spectrum of respiratory pathogens.

Broncho-Vaxom ® prevents and/or reduces the severity of acute attacks of chronic bronchitis and recurrent infections of the respiratory tract, in particular sinusitis, rhinopharyngitis and middle ear infection, in adults and children.

PRODUCTS / BRONCHO-VAXOM®
Properties/Effects 
Composition 
Pharmacokinetics 
Indications 
Dosage and administration
Limitations for use
Adverse effects
Interactions
Overdosage 
Particular remarks 
Presentation
Mechanism of action
BronchoVaxom®
Home Products Company Contact

Broncho-Vaxom ® is an extract of different bacterial species frequently responsible of respiratory infections. It stimulates the immune system in order to increase the body’s natural defences against a wide spectrum of respiratory pathogens.

Broncho-Vaxom ® prevents and/or reduces the severity of acute attacks of chronic bronchitis and recurrent infections of the respiratory tract, in particular sinusitis, rhinopharyngitis and middle ear infection, in adults and children.

Immunostimulating agent

In animals, an increased resistance towards experimental infections, a stimulation of macrophages and B lymphocytes as well as an increase in immunoglobulins secreted by the respiratory mucosal cells have been reported.

In humans, an increase in the rate of circulating T lymphocytes, in salivary IgA, in the non-specific response to polyclonal mitogens and in the mixed lymphocyte reaction have been observed.

Preclinical safety data

Extensive toxicity studies have not revealed any toxic effect.